Background
==========

Influenza is a major cause of morbidity and hospitalization among children \[[@B1]-[@B5]\]. Complications of influenza among children are well-documented, including bronchiolitis, pneumonia, as well as neurological manifestations such as acute encephalopathy and encephalitis \[[@B6]\]. While less often reported in adults, gastrointestinal symptoms have been associated with influenza in children, including abdominal pain, nausea, vomiting, and diarrhea \[[@B7],[@B8]\]. One study reported detection of influenza viral RNA in rectal swabs from two infants confirmed with influenza disease \[[@B9]\].

Diarrhea has been reported among confirmed influenza A (H5N1) cases \[[@B10],[@B11]\], in some cases preceding lower respiratory tract involvement \[[@B12]-[@B14]\]. Detection of influenza A (H5N1) viral RNA and the isolation and identification of influenza A (H5N1) virus, in cell culture, has been reported from rectal swab, stool, and enteral tissue specimens from fatal, confirmed A (H5N1) cases \[[@B15]-[@B17]\]. Despite the recognized clinical association between these enteric manifestations and influenza, limited data are available about whether influenza viruses are present in the gastrointestinal tract of children with influenza-like illness.

Influenza activity occurs year-round in Indonesia, with increased activity during the rainy season (November through April) and peaking in December-January \[[@B18]\]. In addition to seasonal influenza, Indonesia has reported the highest number of influenza A (H5N1) cases worldwide (N = 139, December 2008; <http://www.who.int>), with a case fatality proportion reported between 75% and 80% \[[@B19],[@B20]\]. The epidemiology of human cases of influenza A (H5N1) in Indonesia shows that 96% of the cases occurred in persons \< 40 years of age, 24% \< 10 years of age, with a median age 18.5 years; nearly two-thirds were classified as rural inhabitants \[[@B19]\].

The primary objective of this study was to determine the prevalence of seasonal influenza A and B viruses, and avian influenza A (H5N1) virus, among children seeking medical care with acute influenza-like illness (ILI) and diarrhea in Indonesia.

Methods
=======

Study site and population
-------------------------

Children \< 6 years of age with concurrent diarrhea and acute influenza-like illness presenting at any of 12 study sites (Indonesian Pediatric Diarrhea Network) between September 2005 and April 2008 were eligible for enrollment. Including in the Indonesian Pediatric Diarrhea Network were established study sites located in Jakarta, West Java; Yogyakarta, Central Java; Denpasar, Bali; Mataram, Lombok; Makassar, Sulawesi and Medan, North Sumatra. Stool and upper respiratory (nasal swab and throat swab) specimens were collected from each participant after informed consent was obtained. Nasal swab specimens were collected from the mid-turbinate region and the swab was placed in 2-3 ml of viral transport media (VTM). For throat swabs, both tonsils and the posterior pharynx were swabbed vigorously, and the swab placed in 2-3 ml of VTM. Collected specimens were placed into viral transport media and shipped on ice packs to the laboratory via air or ground courier, within 24 hours after collection. Upon arrival specimens were stored at -70°C until testing. Influenza-like illness was defined as acute fever (\> 38.0°C) with cough or sore throat; diarrhea was defined as three or more loose/liquid stools or two or more loose/liquid stools with one or more associated enteric symptoms (e.g., nausea, vomiting, abdominal cramps, or bloody stool) during any 24 hour period of the current episode. Seasonality was defined as either \'rainy\' season (November through April) or \'dry\' season (May through October) for this study.

Laboratory testing
------------------

Specimen testing was conducted at a central laboratory in Jakarta, Indonesia. RNA was extracted from VTM of throat and nasal swab specimens and stool specimens re-suspended in a 10% solution of PBS using the QIAmp viral RNA mini kit (Qiagen, Hilden, Germany). Identification of influenza type and influenza A subtypes was conducted using multiplex nested reverse-transcription polymerase chain reaction (RT-PCR) as previously described \[[@B21],[@B22]\]. Based on RT-PCR results, a random sample of positive clinical specimens was selected for viral isolation; a random sample of negative specimens was sent for viral culture as well. Briefly, specimens were inoculated onto Madin-Darby canine kidney (MDCK) tissue cells with an aliquot of clinical specimens and incubated for 7 days; indirect immunofluorescence assay (IFA) using specific influenza labeled antibodies was employed to confirm the presence of influenza.

Data analysis
-------------

All data was double-entered into a MS Access (Microsoft Corp., Redmond, Washington, USA) database and statistical testing was conducted using SAS 9.1.13 (SAS Institute, Cary North Carolina, USA).

Ethical Considerations
----------------------

This study was reviewed and approved by the Ethical Commission of the National Institute of Health Research and Development, Indonesian Ministry of Health, Jakarta, Indonesia and by the Institutional Review Board for the ethical conduct of research on human subjects at the U.S. Naval Medical Research Unit No. 2, Jakarta, Indonesia.

Results
=======

Characteristics of patients
---------------------------

From September 2005 through April 2008, 733 pediatric patients (\< 6 years of age) with diarrhea and influenza-like illness were enrolled. Each participant provided matched clinical specimens (stool, one nasal swab and one throat swab) for laboratory analysis. The median age of participants was 15 months (interquartile range (IQR), 9 - 24 months) and 59.5% (436) were male. The median duration of the enrollment diarrhea episode was 1 day (IQR, 1 - 2 days). The median duration of current influenza-like illness episode was 2 days (IQR, 1 - 2). Malnutrition and dehydration among the study participants, subjectively assigned by the enrolling physician, was 7.4% and 25.8%, respectively. Diarrhea severity was subjectively defined by the physician and 71.5% of the study participants were assigned as having either \'mild\' or \'moderate\' diarrhea. Of the 733 study participants, 80 (10.9%) were hospitalized, 11 (1.5%) tested positive for influenza virus by RT-PCR. Table [1](#T1){ref-type="table"} lists the sampling demographics, signs and symptoms, severity of illness and other covariates, stratified by specimen site.

###### 

Demographics, signs and symptoms of study participants stratified by clinical specimen site (n = 733).

  -------------------------------------------------------------------------------------------------------------------
                                             Stool\        **Upper Respiratory**^a^\   Both\         Neither\
                                             (N = 15)      (N = 79)                    (N = 6)       (N = 633)
  ------------------------------------------ ------------- --------------------------- ------------- ----------------
  Age^b^(months)                             12 (9 - 15)   19 (10 - 27)                9 (5 - 27)    14 (8 - 23)

  Diarrhea duration^b^(days)                 2 (1 - 3)     1 (1 - 2)                   1 (1 - 2)     1 (1 - 2)

  Influenza-like illness duration^b^(days)   3 (1 - 4)     2 (1 - 3)                   2 (2 - 3)     2 (1 - 3)

  Fever duration^b^(days)                    2 (1 - 2)     1 (1 - 2)                   1 (1 - 3)     1 (1 - 2)

                                                                                                     

  Gender^c^                                                                                          

   Male                                      10 (66.7%)    44 (55.7%)                  3 (50.0%)     379 (59.9%)

   Female                                    5 (33.3%)     35 (44.3%)                  3 (50.0%)     254 (40.1%)

                                                                                                     

  Age^c^(months)                                                                                     

   0-5                                       0 (0.0%)      2 (2.5%)                    2 (33.3%)     65 (10.3%)

   6-11                                      5 (33.3%)     24 (30.4%)                  1 (0.0%)      176 (27.8%)

   12-23                                     8 (53.3%)     23 (29.1%)                  0 (0.0%)      234 (37.0%)

   24-35                                     1 (6.7%)      16 (20.3%)                  3 (50.0%)     92 (14.5%)

   36-46                                     0 (0.0%)      7 (8.9%)                    0 (0.0%)      37 (5.8%)

   47-71                                     1 (6.7%)      7 (8.9%)                    0 (0.0%)      29 (4.6%)

                                                                                                     

  Diarrhea Severity^c^                                                                               

   Mild                                      4 (26.7%)     29 (36.7%)                  2 (33.3%)     166 (26.7%)^d^

   Moderate                                  10 (66.7%)    28 (35.4%)                  3 (50.0%)     274 (44.1%)^d^

   Severe                                    1 (6.7%)      21 (26.6%)                  1 (16.7%)     182 (29.2%)^d^

                                                                                                     

  Malnutrition^c^                            1 (6.7%)      8 (11.3%)^d^                0 (0.0%)^d^   41 (7.0%)^d^

                                                                                                     

  Fever^c^                                   15 (100%)     79 (100%)                   6 (100%)      633 (100%)

                                                                                                     

  Cough^c^                                   15 (100%)     76 (96.2%)                  6 (100%)      609 (96.2%)

                                                                                                     

  Hospitalization^c^                         2 (13.3%)     8 (10.1%)                   1 (16.7%)     69 (10.9%)
  -------------------------------------------------------------------------------------------------------------------

a\. Upper respiratory is a composite variable of throat and nasal specimen.

b\. Results presented as median (interquartile range)

c\. Results presented as number (percent)

d\. Percent values reflect missing denominator data

Influenza detection
-------------------

Of 733 study participants, influenza virus was detected by RT-PCR in 85 (11.6%) upper respiratory tract specimens and 21 (2.9%) stool specimens. Only six patients had concurrent influenza virus identified from both upper respiratory and stool specimens. Of the 100 patients that tested positive for influenza, influenza A and influenza B virus accounted for 40 (40.0%) and 60 (60.0%), respectively. Of the influenza A viruses identified in upper respiratory specimens, 13 were A (H1N1) and 27 were A (H3N2). Both influenza A and B viruses were detected in stool specimens, including one A (H1N1), three A (H3N2), and 17 B viruses by PCR. In addition to the molecular detection of influenza viral RNA, a subset of randomly selected PCR positive and PCR negative samples (18 and 38, respectively) were submitted for viral culture with a total of 15 (26.8%) positive from upper respiratory specimens. From 25 stool specimens (13 positive and 12 negative by PCR) there was one (4.0%) positive. There were no PCR negative samples that tested positive by viral culture.

Discussion
==========

To our best of our knowledge, this is the largest study investigating influenza virus detection in the gastrointestinal tract of children with influenza-like illness and diarrhea. This study found evidence of influenza viral RNA in 21 (2.9%) stool specimens collected from pediatric patients aged \< 6 years presenting with influenza-like illness (ILI) and diarrhea, thus confirming the findings of a very small study in young children aged 0 - 23 months \[[@B9]\]. The successful recovery of viable influenza B virus from the stool of a single case was notable; it is not clear whether detection of influenza virus in the stool represents active infection of the gastrointestinal tract or swallowed virus from an upper respiratory tract infection. It is possible that influenza viruses might bind to α2,6 sialic acid receptors in the human gastrointestinal tract, and infect and actively replicate within cells in the gastrointestinal tract \[[@B23]\], similar to influenza viruses replication in avian species. However, two studies did not find any evidence for human influenza virus receptors in epithelial cells of the intestinal tract \[[@B24],[@B25]\]. Of interest, influenza virus was the only pathogen detected in several cases of diarrheic children with ILI. Studies are being planned to further confirm these findings and investigate the gastrointestinal activity of influenza virus among influenza positive patients.

We did not detect highly pathogenic avian influenza A (H5N1) viral RNA from any clinical specimens, even though fever and diarrhea have been reported as presenting signs and symptoms in some H5N1 patients \[[@B13],[@B14],[@B19]\]. During the study period, Indonesia reported the highest number of H5N1 human cases of any country <http://www.who.int>, and H5N1 is endemic among poultry in Indonesia, human infection with H5N1 virus continues to be a rare event.

The low yield of influenza virus detected from stool could be due to several factors. It is possible that influenza virus infection and viral shedding in the gastrointestinal tract may be truly low in children with influenza. It is also possible that detection of influenza virus in stool or rectal swab specimens, either by RT-PCR or viral culture, may have been reduced due to inhibitory material present in the gastrointestinal tract and stool. Alternatively, the amount of time, transport time, between specimen collection and inoculation may have rendered the viruses non-viable and subsequently had degradation of influenza target. Additional studies are warranted to further investigate influenza virus detection, including the swine-origin influenza A virus \[[@B26],[@B27]\], in stool specimens of acute ILI patients with and without diarrhea. In addition, studies that further examine influenza virus binding to intestinal tract epithelial tissue, and replication of influenza viruses within the gastrointestinal tract are needed.

Conclusions
===========

The detection of influenza viral RNA and viable influenza virus from stool suggests that influenza virus may be localized in the gastrointestinal tract of children, may be associated with pediatric diarrhea and may serve as a potential mode of transmission during seasonal and epidemic influenza outbreaks.
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